These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1725898)

  • 21. Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 2. Hypotensive effects in normotensive and hypertensive rats.
    Kawakami M; Matsumura S; Shimamura T; Iwasaki T; Furukawa H; Matsunaga K; Yonetani Y; Iwaki K
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):695-702. PubMed ID: 8945684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
    Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
    Petty MA; Mir AK
    Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative antihypertensive effects of nifedipine and nicardipine in adult and aged spontaneously hypertensive rats.
    Pruneau D; Roy F
    Arzneimittelforschung; 1987 Apr; 37(4):416-8. PubMed ID: 3606696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effect of CV-4093.2HCl, a new calcium antagonist, in three rat models of hypertension.
    Kakihana M; Suno M; Nagaoka A
    Jpn J Pharmacol; 1988 Oct; 48(2):223-8. PubMed ID: 3210447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F; Clozel JP; Osterrieder W
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
    Tasaka K; Kamei C; Tagami H; Hokonohara T; Sugimoto Y
    Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
    Pruneau D; Brown NL
    Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive effect of felodipine, a new calcium antagonist].
    Inoue T; Omosu M; Hayashi S; Sakaguchi S; Nakao K; Inukai T; Odagiri N; Ono T
    Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):453-62. PubMed ID: 1464403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
    Nakayama N; Ikezono K; Mori T; Yamashita S; Nakayama S; Tanaka Y; Hosokawa T; Minami Y; Masutani K; Yamamura Y
    J Cardiovasc Pharmacol; 1990 May; 15(5):836-44. PubMed ID: 1692946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effect of a new dihydropyridine calcium entry blocker in conscious hypertensive and normotensive rats.
    Nomura M; Kimura Y; Yoshida M; Satoh S
    Arzneimittelforschung; 1989 Dec; 39(12):1542-5. PubMed ID: 2624602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive effects of long-term treatment with AE0047, a novel long-lasting calcium antagonist, in hypertensive models of rats and dogs].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ebisu H; Egi Y; Shinyama H; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):291-301. PubMed ID: 9253776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypotensive effects of diltiazem hydrochloride in the normotensive, spontaneously hypertensive and renal hypertensive rats (author's transl)].
    Sato M; Murata S; Narita H; Tomita M; Yamashita K; Yamaguchi I
    Nihon Yakurigaku Zasshi; 1979 Mar; 75(2):99-106. PubMed ID: 535823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypotensive effects of dihydropyridine derivatives.
    Kamei C; Kurokawa K; Tasaka K
    Arzneimittelforschung; 1985; 35(9):1377-80. PubMed ID: 2935160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of single and repeated oral administration of MK-421 and captopril on blood pressures in normotensive and experimental hypertensive rats].
    Ohmura I; Maki E; Naruse T; Chen CS; Ikeda N; Asami T
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):293-302. PubMed ID: 3002925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotensive effects of YM430, a 1,4-dihydropyridine derivative, in spontaneously hypertensive rats and renal hypertensive dogs.
    Shibasaki K; Takizawa K; Uchida W; Takenaka T
    Jpn J Pharmacol; 1997 Feb; 73(2):113-24. PubMed ID: 9074945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of diltiazem, a calcium antagonist: coronary vasodilating and antihypertensive actions.
    Nagao T; Narita H; Sato M; Nakajima H; Kiyomoto A
    Clin Exp Hypertens A; 1982; 4(1-2):285-96. PubMed ID: 7074990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.